Endovascular brachytherapy for the prevention of restenosis after femoropopliteal angioplasty. Results of the VARA trial

Journal of Cardiovascular Surgery

Volumn 46, Issue 4, 2005, Pages 437-443

  van Tongeren, R B ^a,b   van Sambeek, M R H M ^c   van Overhagen, H ^b   Coen, V L ^c,d   Schmitz, P I ^c   Gescher, F M ^b   Wittens, C H ^e   Vernhout, R M ^c   van Urk, H ^c   Levendag, P C ^c   Bruijninckx, C M ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEYENBURG HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Institution for Radiotherapy Zeeland   (Netherlands)

^e SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Angioplasty, transluminal; Endovascular brachytherapy; Intimal hyperplasia; Peripheral arterial disease; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BRACHYTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FEMOROPOPLITEAL BYPASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE PERIOD; PRIMARY PREVENTION; PROSPECTIVE STUDY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RESTENOSIS; RISK REDUCTION; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY; ANGIOSCOPY; ARTERIAL OCCLUSIVE DISEASES; BRACHYTHERAPY; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POPLITEAL ARTERY; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 27744532885     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Murray RRJ, Hewes RC, White RIJ, Mitchel SE, Auster M, Chang R et al. Long-segment femoropopliteal stenoses: is angioplasty a boon or a bust? Radiology 1987;162:473-6.
2. Matsi PJ, Manninen HI, Vanninen RL, Suhonen MT, Oksala I, Laakso M et al. Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3-year follow-up. Radiology 1994;191:727-33.
3. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1993;186:207-12.
4. Davies MG, Hagen PO. Pathobiology of intimal hyperplasia. Br J Surg 1994;81:1254-69.
5. Post MJ, Borst C, Pasterkamp G, Haudenschild CC. Arterial remodeling in atherosclerosis and restenosis: a vague concept of a distinct phenomenon. Atherosclerosis 1995;118(Suppl):115-23.
6. Herrman JP, Hermans WR, Vos J, Serruys PW. Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? Drugs 1993;46:18-52.
7. Waksman R, Robinson KA, Crocker IR, Gravanis MB, Cipolla GD, King SB. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. A possible role for radiation therapy in restenosis prevention. Circulation 1995;91:1533-9.
8. Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol 1994; 23:1491-8.
9. Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J. Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up. J Am Coll Cardiol 1995;25:1451-6.
10. Mazur W, Ali MN, Khan MM, Dabaghi SF, DeFelice CA, Paradis P Jr et al. High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis: angiographic, morphometric, and histopathologic analyses. Int J Radiat Oncol Biol Phys 1996;36:777-88.
11. Hehrlein C, Gollan C, Donges K, Metz J, Riessen R, Fehsenfeld P et al. Low-dose radioactive endovascular tents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 1995;92:1570-5.
12. Laird JR, Carter AJ, Kufs WM, Hoopes TG, Farb A, Nott SH et al. Inhibition of neointimal proliferation with low-dose irradiation from a beta-particle-emitting stent. Circulation 1996; 93:529-36.
13. Verin V, Popowski Y, Urban P, Belenger J, Redard M, Costa M et al. Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model. Circulation 1995;92:2284-90.
14. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-703.
15. King SB 3rd, Williams DO, Chougule P, Klein JL, Waksman R, Hilstead R et al. Endovascular beta-irradiation to reduce restenosis after coronary balloon angioplasty. Results of the beta energy restenosis trial (BERT). Circulation 1998;97:2025-30.
16. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlbock M et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty. Circulation 2000; 102:2694-9.
17. 192Ir endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: years of experience. Int J Radiat Oncol Biol Phys 1996;36:835-40.
18. Zehnder T, von Briel C, Baumgartner I, Triller J, Greiner R, Mahler F et al. Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions. J Endovasc Ther 2003;10:304-11.
19. Waksman R, Laird JR, Jurkovitz CT, Lansky AJ, Gerrits F, Kosinski AS et al. Peripheral Artery Radiation Investigational Study (PARIS) Investigators. Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. J Vasc Interv Radiol 2001;12:915-21.
20. Krueger K, Landwehr P, Bendel M, Nolte M, Stuetzer H, Bongartz R et al. Endovascular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of prospective randomized controlled trial. Radiology 2002;224: 519-28.
21. Pokrajac B, Potter R, Maca T, Fellner C, Mittlbock M, Ahmadi R et al. Intra-arterial 192Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis. Int J Radiat Oncol Biol Phys 2000;48:923-31.
22. Hansrani M, Overbeck K, Smout J, Stansby G. Intravascular brachytherapy for peripheral vascular disease (Cochrane Review). In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons; 2004.
23. Albiero R, Nishida T, Adamian M, Amato A, Vaghetti M, Corvaja N et al. Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents. Circulation 2000;101:2454-7.
24. Wolfram RM, Pokrajac B, Ahmadi R, Fellner C, Gyongyosi M, Haumer M et al. Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results. Radiology 2001;220:724-9.
25. Hansrani M, Overbeck K, Smout J, Stansby G. Intravascular brachytherapy: a systematic review of its role in reducing restenosis after endovascular treatment in peripheral arterial disease. Eur J Vasc Endovasc Surg 2002;24:377-82.